Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 294,911 | 231,110 | 244,785 | 303,222 | 418,358 |
| Marketable Securities | 319,697 | 407,440 | 459,033 | 445,855 | 343,826 |
| Receivables | 11,172 | 12,549 | 11,535 | 9,342 | 6,706 |
| Inventories | 834 | 836 | 1,136 | 1,233 | 966 |
| TOTAL | $626,813 | $652,155 | $717,531 | $759,924 | $770,450 |
| Non-Current Assets | |||||
| PPE Net | 1,710 | 1,808 | 794 | 680 | 710 |
| Investments And Advances | 382,637 | 340,504 | 289,733 | 236,574 | 239,666 |
| Intangibles | 19,979 | 19,313 | 17,475 | 17,161 | 15,506 |
| Other Non-Current Assets | 43,232 | 44,411 | 26,299 | 27,067 | 2,801 |
| TOTAL | $447,558 | $406,036 | $334,301 | $281,482 | $258,683 |
| Total Assets | $1,074,371 | $1,058,191 | $1,051,832 | $1,041,406 | $1,029,133 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,481 | 8,323 | 752 | 5,401 | 4,100 |
| Accrued Expenses | N/A | N/A | 5,348 | N/A | N/A |
| TOTAL | $19,912 | $20,200 | $17,185 | $17,743 | $14,697 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 13 | 183 | 247 | 268 |
| Other Non-Current Liabilities | 5,608 | 4,646 | 4,615 | 3,261 | 1,085 |
| TOTAL | $6,339 | $5,440 | $4,615 | $3,261 | $1,127 |
| Total Liabilities | $26,251 | $25,640 | $21,800 | $21,004 | $15,824 |
| Shareholders' Equity | |||||
| Common Shares | 761,982 | 761,913 | 761,844 | 761,788 | 761,595 |
| Retained earnings | 256,267 | 237,311 | 232,122 | 231,901 | 218,971 |
| Other shareholders' equity | 14,390 | 18,544 | 21,740 | 12,850 | 19,360 |
| TOTAL | $1,048,120 | $1,032,551 | $1,030,032 | $1,020,402 | $1,013,309 |
| Total Liabilities And Equity | $1,074,371 | $1,058,191 | $1,051,832 | $1,041,406 | $1,029,133 |